BioLife Solutions Stock Price and Value Analysis

Should you buy BioLife Solutions stock? (NasdaqCM:BLFS). Let's see how it does in our automated value investing analysis system.

AdvantagesDisadvantagesNeutral
None.
  • This company is not making money.
  • This company is less known than others.
  • This stock looks overpriced.
  • This company has wild ups and downs.
  • This company pays no dividend.

Inside the BLFS Numbers

BLFS Price
(BioLife Solutions stock price per share)
$16.17
[?] PE Ratio versus Sector 486% higher than other Healthcare stocks
[?] PE Ratio versus Industry 393% higher than other Medical Instruments & Supplies stocks
[?] Free Cash Flow Jitter 43%

Is BioLife Solutions Stock on Sale?

Based on our analysis, we believe that you should not buy BioLife Solutions right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.

Should You Buy BLFS Stock?

Does BioLife Solutions have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.